HELP Therapeutics
China - NanjingBiotechnology
Focus: HELP Therapeutics is a China-based biotech specialist in induced pluripotent stem cell (iPSC) therapies and stem cell services, founded in 2016 and operating at Series C+ stage. The company focuses on regenerative medicine applications across cardiovascular, neurological, and hematologic indications.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
SERIES C +
Open Jobs
0
About HELP Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow HELP Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Nutritional educational intervention
MalnutritionClinical Trials (1)
NCT06195098The Tany Vao Project.
N/AHelp build intelligence for HELP Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.